Mulberry Biotherapeutics, Inc
Mulberry Biotherapeutics, Inc., based in Wellesley Hills, MA, is dedicated to improving the health and quality of life for individuals affected by neurofibromatosis Type 2 (NF2) and other rare genetic disorders. The company is pioneering novel bacteria-mediated therapies aimed at targeting non-cancerous neoplasms, particularly schwannomas, which significantly impact patients' lives.
With a platform centered around the engineered strain MUL001 of Salmonella typhimurium, Mulberry Biotherapeutics focuses on delivering precise treatments through intra-tumoral injections. The company works in collaboration with research leaders and experts in schwannoma biology to advance their innovative therapeutic approaches and address unmet medical needs in the rare disease community.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
